We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
(+7.4%)
Cap. Flow
+$4.03M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7
Avg Time Held
2.1
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
4.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis US Small Cap Value ETF
AVUV
|
+$3.94M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.93M |
| 3 |
Neumora Therapeutics
NMRA
|
+$3.31M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$2.97M |
| 5 |
Microsoft
MSFT
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$16M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$5.85M |
| 3 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$3.04M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$2.44M |
| 5 |
Edwards Lifesciences
EW
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.4% |
| 2 | Technology | 5.18% |
| 3 | Healthcare | 2.32% |
| 4 | Financials | 1.59% |
| 5 | Consumer Discretionary | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Schwab US Broad Market ETF
SCHB
$44.9B
| $124M | 10.87% |
6,074,580
-302,268
| -5% | -$5.85M |
2015 Q3
34 quarters
|
|
2
Schwab Fundamental US Large Company Index ETF
FNDX
$28.1B
| $79.8M | 7.01% |
3,551,373
-75,849
| -2% | -$1.61M |
2019 Q1
20 quarters
|
|
|
3
Schwab International Equity ETF
SCHF
$67B
| $79.6M | 6.99% |
4,077,598
-130,404
| -3% | -$2.44M |
2015 Q3
34 quarters
|
|
4
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $68.8M | 6.05% |
1,932,676
-16,724
| -0.9% | -$568K |
2016 Q2
31 quarters
|
|
|
5
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $43.4M | 3.82% |
857,775
+77,474
| +10% | +$3.93M |
2022 Q2
7 quarters
|
|
6
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $39.2M | 3.45% |
1,019,526
-3,225
| -0.3% | -$117K |
2013 Q2
43 quarters
|
|
7
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.5B
| $38.8M | 3.41% |
1,082,339
-32,298
| -3% | -$1.11M |
2021 Q4
9 quarters
|
|
8
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.5B
| $30.5M | 2.68% |
1,382,841
-5,358
| -0.4% | -$112K |
2016 Q2
31 quarters
|
|
9
Avantis International Small Cap Value ETF
AVDV
$19.9B
| $30.1M | 2.65% |
457,307
+12,946
| +3% | +$807K |
2021 Q4
9 quarters
|
|
10
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.92B
| $27.8M | 2.45% |
812,043
-25,860
| -3% | -$856K |
2019 Q3
18 quarters
|
|
|
11
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $26M | 2.28% |
621,947
+72,771
| +13% | +$2.97M |
2020 Q1
16 quarters
|
|
12
iShares International Equity Factor ETF
INTF
$3.69B
| $25.2M | 2.22% |
844,576
-18,118
| -2% | -$518K |
2020 Q2
15 quarters
|
|
13
Apple
AAPL
$4.99T
| $23.9M | 2.1% |
139,307
+1,577
| +1% | +$287K |
2017 Q2
27 quarters
|
|
|
14
Avantis US Small Cap Value ETF
AVUV
$30.9B
| $21.5M | 1.89% |
228,973
+44,538
| +24% | +$3.94M |
2023 Q1
4 quarters
|
|
15
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $20.7M | 1.82% |
199,228
-4,376
| -2% | -$443K |
2013 Q2
43 quarters
|
|
16
Schwab Fundamental US Small Company Index ETF
FNDA
$8.78B
| $19.8M | 1.74% |
695,858
-588
| -0.1% | -$16K |
2018 Q3
22 quarters
|
|
17
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
| $19.5M | 1.71% |
303,342
-29,706
| -9% | -$1.81M |
2022 Q1
8 quarters
|
|
18
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.3B
| $19.4M | 1.71% |
186,974
-9,737
| -5% | -$960K |
2015 Q4
33 quarters
|
|
19
Vanguard Information Technology ETF
VGT
$150B
| $18.6M | 1.63% |
283,328
-11,392
| -4% | -$722K |
2017 Q1
28 quarters
|
|
20
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $16.4M | 1.44% |
279,130
-2,588
| -0.9% | -$146K |
2013 Q2
43 quarters
|
|
21
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.5B
| $14.2M | 1.25% |
513,245
+88,887
| +21% | +$2.4M |
2021 Q4
9 quarters
|
|
22
Dimensional International Small Cap Value ETF
DISV
$5.09B
| $12M | 1.06% |
441,453
-9,082
| -2% | -$234K |
2022 Q2
7 quarters
|
|
23
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.65B
| $11.6M | 1.02% |
296,235
-923
| -0.3% | -$34.4K |
2013 Q2
43 quarters
|
|
24
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $11.4M | 1% |
77,335
-1,873
| -2% | -$269K |
2013 Q2
43 quarters
|
|
|
25
Microsoft
MSFT
$4.01T
| $10.8M | 0.95% |
25,562
+6,042
| +31% | +$2.45M |
2020 Q1
16 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.
- Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
- Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
- Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
- Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
- Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
- Callan Capital opened 70 new positions and closed 7 in Q1 2024.
- Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.
Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.